Therapeutic potential of ADSC-EV-derived lncRNA DLEU2: A novel molecular pathway in alleviating sepsis-induced lung injury via the miR-106a-5p/LXN axis.
He W, Xu C, Huang Y, Zhang Q, Chen W, Zhao C, Chen Y, Zheng D, XinyueLin, Luo Q, Chen X, Zhang Z, Wu X, Huang J, Lin C, Huang Y, Zhang S.
He W, et al. Among authors: wu x.
Int Immunopharmacol. 2024 Mar 30;130:111519. doi: 10.1016/j.intimp.2024.111519. Epub 2024 Mar 4.
Int Immunopharmacol. 2024.
PMID: 38442573